Reichenberg A, Caspi A, et al: Am J Psychiatry 2010; 167 (February): 160-169 Cognitive deficits appear to be present years before the onset of schizophrenia, particularly in the areas of executive functioning.
Which Comes First --Obesity or Depression?
Overweight, Obesity, and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Luppino FS, de Wit LM, et al: Arch Gen Psychiatry 2010; 67 (March): 220-229 Pooled longitudinal data looking at the onset of depression and obesity indicate that rather than a causal relationship between the two, there appears to be a reciprocal relationship.
Background/Objective: Depression and obesity are highly prevalent health issues and present important public health challenges. There has been growing interest on how these 2 conditions might be related, that is one causing or predisposing towards the other. There have been some longitudinal studies that might better clarify these relationships. This study enhances what we might learn from them by conducting a meta-analysis of the data from such prior work. Methods: A computerized literature search was performed to identify longitudinal cohort studies of the relationship and appearance over time of depressive disorder, depressive symptom, being in an overweight condition, and body mass index (BMI)-defined frank obesity. Papers were scored in terms of their acceptability in terms of methodological rigor and design. Fifteen studies were included. Results: Pooling the 15 studies created data for 58745 subjects. Baseline obesity significantly increased the odds of later development of depression (OR, 1.55). The relationship was stronger for diagnosed depressive disorder rather than just a change in level of measured depressive symptoms. For people >20 years of age, but not below it, being overweight also increased the risk of later depression (OR, 1.51). Having depression at baseline significantly increased the risk of later being obese (OR, 1.58), but interestingly, not of being overweight. Conclusions: All things being equal, obesity and overweight appear to increase later risk of depression, and depression appears to increase later risk of obesity, but not overweight. Reviewer's Comments: This apparent reciprocal relationship between depression and obesity adds complexity to the putative biological or psychological mechanisms that have been offered to explain one direction of the relationship or another. Also, the relationship between depression and later obesity, but not overweight, if replicated, might indicate some ways in which obesity is distinctly precipitated and sustained. (Reviewer-Gary S. Belkin, MD, PhD, MPH). Obesity and diabetes appear to be associated with the later onset of Alzheimer's dementia, which may prove to be an added public health concern to our "obesity epidemic."
Obesity and Alzheimer's --A Warning Shot Is Fired
Background: Established major risk factors for late-onset Alzheimer's disease (AD) include advanced age beginning in the seventh decade, carriage of an apolipoprotein E epsilon4 (APOE4) allele, and a family history of AD. There have been conflicting reports of whether obesity and diabetes also increase the risk for development of AD. Objective: To systematically review the literature regarding obesity and diabetes as potential AD risk factors, to quantify their associations with AD, and to identify mechanisms whereby they might increase the risk for AD. Methods: The authors searched the PubMed database and included studies in the meta-analysis that reported separate risk statistics for AD by antecedent diagnosis or characterization of diabetes, metabolic syndrome, disorders of glucose or insulin levels, or body mass index (BMI) consistent with World Health Organization criteria for obesity.
Results:
The meta-analysis yielded a highly significant pooled effect size for AD of 1.59 with obesity and of 1.54 with diabetes. A different meta-analysis combining all studies for obesity, diabetes, and abnormal glucose or insulin levels yielded a larger pooled effect size of 1.63. Taken together, the reviewed studies suggest that obesity and diabetes in mid-life and late-life increase the risk for AD and are consistent with AD pathogenesis beginning many years prior to the clinical onset of AD. The increased risk for AD due to obesity and diabetes appears to be independent of one another, other often comorbid vascular risk factors, and possibly also the APOE4 allele.
Conclusions:
The results from this meta-analysis confirm a small but significantly increased risk for AD with obesity and diabetes. Reviewer's Comments: Obesity and diabetes being risk factors for vascular dementia seems readily comprehensible. However, the same cannot be said of the findings of this study, which demonstrate that these metabolic risk factors are also associated with AD, a disease involving the tau protein phosphorylation or amyloid precursor protein expression and processing. Potential causal mechanisms may be related to changes in adipose tissue physiology and in levels of systemic hormones, such as leptin, cortisol, estrogen, thyroid hormone, and growth hormone, and insulin-like growth factor affecting the hippocampus. Whichever the causal mechanism, or, more likely, multiple mechanisms, the implication of the findings in this meta-analysis are tremendous in regard to the potential for disease burden of Alzheimer's in decades to come. Close to half of the U.S. population is either obese or has diabetes. (Reviewer-John G. Koutras, MD).
When Body Dysmorphic Disorder Completely Escapes Reality
Delusional Versus Nondelusional Body Dysmorphic Disorder. It is important to ascertain the level of insight in BDD in order to have a better clinical sense of severity and possible refractoriness to SSRIs.
Background:
In those with body dysmorphic disorder (BDD), the preoccupation with a perceived or minor defect in one's appearance consumes, on average, 3 to 8 hours daily. Although not part of the diagnostic criteria, individuals with BDD perform compulsive behaviors to examine, improve, or hide their perceived defect. Insight into these bodily preoccupations is often impaired; BDD patients hold these beliefs with strong conviction. Patients who have a delusional intensity qualify for an additional diagnosis of delusional disorder, somatic type. Both delusional and nondelusional variants of BDD may reflect 1 single disorder, with the degree of insight varying along a continuum. Delusional patients have greater impairment in occupational or academic functioning than do nondelusional patients. Pharmacotherapy trials consistently indicate that selective serotonin reuptake inhibitors (SSRIs) are often efficacious in treating both delusional and nondelusional variants of BDD.
Objective: This Australian sample of BDD patients compares demographics, clinical features, and treatment response between patients classified as delusional and nondelusional. Participants/Methods: 65 patients with BDD were administered the following measures: Body Dysmorphic Disorder Questionnaire; Dysmorphic Concern Questionnaire; Self-Rating Depression Scale; Social Interaction Anxiety Scale; BDD Yale-Brown Obsessive-Compulsive Scale; and the Clinical Global Impressions (CGI) Scale. The patients were then treated with a standardized pharmacological protocol; citalopram or escitalopram were the first-line choice, and if poorly tolerated, then venlafaxine was the second-line choice. An adjunctive atypical antipsychotic (quetiapine) was used if the response to the SSRI was suboptimal. Results: 60% of the patients were classified as currently delusional and 40% as nondelusional. The 2 groups did not differ on most demographic characteristics, although delusional patients were less likely to be female or employed. There were no significant differences between delusional and nondelusional patients in relation to the age of BDD onset and duration. Delusional patients had more severe BDD symptoms on the standardized measures and less improvement on the CGI. In terms of psychiatric comorbidity, there were no significant differences in comorbidity between the 2 groups. Overall, fewer delusional patients responded to treatment than nondelusional patients. Conclusions: BDD appears to occur within a spectrum of insight, with delusional patients having a more severe form of the disorder. (Reviewer-John G. Koutras, MD).
